Compare MOLN & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MOLN | SEVN |
|---|---|---|
| Founded | 2004 | 1986 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.5M | 167.9M |
| IPO Year | 2021 | 2008 |
| Metric | MOLN | SEVN |
|---|---|---|
| Price | $3.56 | $6.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $10.36 | $9.55 |
| AVG Volume (30 Days) | 2.0K | ★ 182.5K |
| Earning Date | 10-29-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 16.23% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $29,383,000.00 |
| Revenue This Year | N/A | $18.67 |
| Revenue Next Year | $450.00 | $12.98 |
| P/E Ratio | ★ N/A | $36.32 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.52 | $6.70 |
| 52 Week High | $5.36 | $10.90 |
| Indicator | MOLN | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 36.40 | 37.61 |
| Support Level | N/A | $6.70 |
| Resistance Level | $4.59 | $7.84 |
| Average True Range (ATR) | 0.13 | 0.18 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 5.13 | 21.21 |
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.